TYRO3 and ovarian carcinoma: In human ovarian cancer SKOV3 cells and the chemoresistant ovarian cancer SKOV3/TR cells, apigenin significantly decreased Axl and Tyro3 receptor tyrosine kinase at both RNA and protein levels, without changing the IL-6 production and phospho-STAT3 protein levels [100].